VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Us2.ai has a feature that leverages the speed of our AI,

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Nov 11, 2024 3:34pm

46 Views

Post# 36307119

RE:Us2.ai has a feature that leverages the speed of our AI,

Interesting click https://ascendcv.com/product-and-services/gen3echo/# Integrations Just click on "Integrations".see

Seamless, flexible integration with heterogeneous AI, imaging and enterprise IT environments enables a best-of breed approach. Examples include:

Us2.ai - Benefit from the the industry’s most sophisticated integration of Us2.ai.
- Us2.ai FDA-approved measurements feed ASE-validated suggested interpretations that can automatically complete the echo report
- Save time with single-click navigation to the automated measurement source frame
- 1-click sync to automated measurement frame
- Distinct review processes for FDA-cleared versus investigational measurements, enhancing compliance and clarity
- Automatic grouping of Us2.ai measurements accelerates the measurement review process
- Visual notification of user edits performed on Us2.ai measurements promotes transparency and traceability
Engineered for seamless integration: Gen3Echo was designed with commitment to openness, seamlessly integrating with AI, ML, and advanced visualization software to foster innovation and collaboration.
- Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients. Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care.